Starling Oncology, Inc. Long-Term Debt, Maturity, Year Two
Starling Oncology, Inc. (DFPH) had Long-Term Debt, Maturity, Year Two of $85.89 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-03-12
- 2025-12-31: Long-Term Debt, Maturity, Year Two $85.89M.
- 2025-09-30: Long-Term Debt, Maturity, Year Two $85.89M.
- 2025-06-30: Long-Term Debt, Maturity, Year Two $85.89M.
- 2025-03-31: Long-Term Debt, Maturity, Year Two $85.89M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2025-12-31 | $85.89M 10-K · filed 2026-03-12 |
| 2025-09-30 | $85.89M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $85.89M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $85.89M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-26 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |